871567-47-4Relevant articles and documents
Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group
Wu, Tom Y. H.,Hassig, Christian,Wu, Yiqin,Ding, Sheng,Schultz, Peter G.
, p. 449 - 453 (2007/10/03)
Histone deacetylases (HDAC) are promising targets for cancer chemotherapy. HDAC inhibitors are thought to act in part by disrupting normal cell cycle regulation, resulting in apoptosis and/or differentiation of transformed cells. Several HDAC inhibitors,